These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 18711456
1. Tranexamic acid in the treatment of pediatric traumatic hyphema. Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN. Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456 [Abstract] [Full Text] [Related]
2. An analysis of risk for secondary hemorrhage in traumatic hyphema. Rahmani B, Jahadi HR, Rajaeefard A. Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494 [Abstract] [Full Text] [Related]
3. Outpatient management of traumatic hyphemas in children. Coats DK, Viestenz A, Paysse EA, Plager DA. Binocul Vis Strabismus Q; 2000 Feb; 15(2):169-74. PubMed ID: 10893460 [Abstract] [Full Text] [Related]
8. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Pieramici DJ, Goldberg MF, Melia M, Fekrat S, Bradford CA, Faulkner A, Juzych M, Parker JS, McLeod SD, Rosen R, Santander SH. Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516 [Abstract] [Full Text] [Related]
9. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001). Romano PE, Robinson JA. Binocul Vis Strabismus Q; 2000 Nov; 15(2):175-86. PubMed ID: 10893461 [Abstract] [Full Text] [Related]
10. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial. Derakhshan A, Firoozi J, Esmaeili S, Bakhtiari E, Abbaspour M, Abrishami M, Zia MJ. J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502 [Abstract] [Full Text] [Related]
11. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children. Teboul BK, Jacob JL, Barsoum-Homsy M, Brunette I, Chevrette L, Milot J, Orquin J, Polomeno RC, Quigley MG. Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257 [Abstract] [Full Text] [Related]
12. Opposition to treatment of traumatic hyphema with antifibrinolytics/steroids. Romano PE, Smith RJ. Binocul Vis Strabismus Q; 2000 Nov; 15(2):163-5. PubMed ID: 10893458 [No Abstract] [Full Text] [Related]
13. Clinical features, management and visual outcomes on patients with traumatic hyphema in a reference ophthalmological clinic in Colombia. Galvis V, Pedraza-Concha A, Tello A, Plata ML, Escaf CL, Berrospi DR. Rom J Ophthalmol; 2020 Nov; 64(1):28-34. PubMed ID: 32292855 [Abstract] [Full Text] [Related]
14. Tranexamic acid in the prevention of secondary haemorrhage after traumatic hyphaema. Uusitalo RJ, Saari MS, Aine E, Saari KM. Acta Ophthalmol (Copenh); 1981 Aug; 59(4):539-45. PubMed ID: 7315210 [Abstract] [Full Text] [Related]
15. Recurrent bleeding following traumatic hyphema due to mild hemophilia B (Christmas disease). Wilker SC, Singh A, Ellis FJ. J AAPOS; 2007 Dec; 11(6):622-3. PubMed ID: 17720569 [Abstract] [Full Text] [Related]
16. Management of traumatic hyphema in children. An analysis of 340 cases. Uusitalo RJ, Ranta-Kemppainen L, Tarkkanen A. Arch Ophthalmol; 1988 Sep; 106(9):1207-9. PubMed ID: 3415544 [Abstract] [Full Text] [Related]
18. Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid. Bramsen T. Acta Ophthalmol (Copenh); 1976 Apr; 54(2 p):250-6. PubMed ID: 946728 [Abstract] [Full Text] [Related]
19. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema. Nasrullah A, Kerr NC. Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622 [Abstract] [Full Text] [Related]
20. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema. Karkhaneh R, Naeeni M, Chams H, Abdollahi M, Mansouri MR. Eur J Ophthalmol; 2003 Jun; 13(1):57-61. PubMed ID: 12635675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]